Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 12/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
| ▸ | MAX | P61244 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6889362 | 0.87 | ALDH1A1 (0.39) | HCAR3PDK1LMNA | |
| SCHEMBL17511817 | 0.81 | HCAR3 (0.58) | HCAR3TSHRCASP6LMNA | |
| SCHEMBL6892370 | 0.77 | HCAR3 (0.55) | HCAR3TSHRCASP6PDK1LMNA | |
| SCHEMBL29886944 | 0.77 | HCAR3 (0.55) | HCAR3TSHRCASP6PDK1LMNA | |
| SCHEMBL16129649 | 0.75 | HCAR3 (0.56) | HCAR3TSHRCASP6LMNA | |
| SCHEMBL4175596 | 0.74 | CASP6 (0.58) | HCAR3TSHRCASP6LMNA | |
| SCHEMBL28748754 | 0.72 | HCAR3 (0.51) | HCAR3TSHRCASP6PDK1LMNA | |
| SCHEMBL2366810 | 0.71 | HCAR3 (0.61) | HCAR3TSHRCASP6LMNA | |
| SCHEMBL20757 | 0.71 | PDK1 (0.68) | HCAR3TSHRCASP6PDK1LMNA | |
| SCHEMBL6707224 | 0.71 | MYC (0.55) | HCAR3TSHRCASP6LMNAMYC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004089529-A1 | METHOD FOR THE INTRAMOLECULAR ENERGY TRANSFER FOR THE CLEAVAGE OF LABILE FUNCTIONAL GROUP FROM BIOMOLECULES AND THE PROTECTED BIOMOLECULES | Universität Konstanz (DE) | 2004-10-21 | — | — | WO | disclosed |